RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Commercial Update
20.03.2023 - - RVLP records exceptional year-over-year growth with UPNEEQ launch into the medical aesthetics market - - Full year 2022 total revenues of $49.7 million, an increase of $32.2 million, or 184%, over 2021 - - Full year 2022 UPNEEQ net product sales ...